• 1
    Katlama C, Carcelain G, Duvivier C et al. Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM study- ANRS 082. AIDS 2002; 16: 202734.
  • 2
    Levy Y, Durier C, Krzysiek R et al. Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial. AIDS 2003; 17: 34351.
  • 3
    Pahwa S, Muresan P, Sleasman J et al. Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402. J. Allergy Clin. Immunol. 2007; 119: 153841.
  • 4
    Proleukin® 18x106 UI. Product information. Novartis. May 2005.
  • 5
    Yu J, Chen H, Horton H et al. Interleukin-2 reconstitutes defective human immunodeficiency virus (HIV) and cytomegalovirus (CMV)-specific CD8+ T cell proliferation in HIV infection. J. Med. Virol. 2006; 78: 114757.